Activating mTOR mutations in a patient with an extraordinary response on a phase I trial of everolimus and pazopanib (Q27852954)
scientific article
Language:
Current Data About Activating mTOR mutations in a patient with an extraordinary response on a phase I trial of everolimus and pazopanib
(P31) (Q13442814)
(P248)
(P698) 24625776
(P813) Sunday, November 13, 2016

(P50) (Q970550)
(P1545) 18

(Q32646710)
(P1545) 4

(Q42862184)
(P1932) Jonathan E Rosenberg
(P1545) 22

(Q55130361)
(P1932) Leena Gandhi
(P1545) 9

(Q42532150)
(P1932) Philip W Kantoff
(P1545) 20

(Q63146189)
(P1545) 15
(P1932) Massimo Loda

(Q32649203)
(P1545) 19
(P1932) Stacey B Gabriel

(Q80164282)
(P1545) 12
(P1932) Mary Ellen Taplin

(Q89916155)
(P1545) 21
(P1932) Levi A Garraway

(Q88414622)
(P1545) 8
(P1932) Toni K Choueiri

(Q16231524)
(P1545) 17
(P1932) David M Sabatini

(Q90424571)
(P1545) 14
(P1932) Sabina Signoretti

(P304) 546-53

(P407) (Q1860)

(P433) 5

(P478) 4

(P577) +2014-05-00T00:00:00Z

(P921) (Q5452194)

(Q181600)
(P887)

(P1433) (Q15724440)
(P248)

(P1476) "Activating mTOR mutations in a patient with an extraordinary response on a phase I trial of everolimus and pazopanib" (language: en)
(P248)
(P698) 24625776
(P813) Sunday, November 13, 2016

(P2093) Nikhil Wagle
(P1545) 1

Brian C Grabiner
(P1545) 2

Eliezer M Van Allen
(P1545) 3

Susanna Jacobus
(P1545) 5

Jeffrey G Supko
(P1545) 6

Michelle Stewart
(P1545) 7

James M Cleary
(P1545) 10

Aymen A Elfiky
(P1545) 11

Edward C Stack
(P1545) 13

Geoffrey I Shapiro
(P1545) 16

(P2860) (Q24606956)
(P248)
(P854) https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4122326
(P813) Monday, March 20, 2017

(Q27677954)
(P248)
(P854) https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4122326
(P813) Monday, March 20, 2017

(Q24631915)
(P248)
(P854) https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4122326
(P813) Monday, March 20, 2017

(Q24608391)
(P248)
(P854) https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4122326
(P813) Monday, March 20, 2017

(Q27732817)
(P248)
(P854) https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4122326
(P813) Monday, March 20, 2017

(Q27860948)
(P248)
(P854) https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4122326
(P813) Monday, March 20, 2017

(Q28131668)
(P248)
(P854) https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4122326
(P813) Monday, March 20, 2017

(Q29547693)
(P248)
(P854) https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4122326
(P813) Friday, April 7, 2017

(Q29615711)
(P248)
(P854) https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4122326
(P813) Friday, April 7, 2017

(Q38099308)
(P248)
(P854) https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4122326
(P813) Friday, September 29, 2017

(Q38077440)
(P248)
(P854) https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4122326
(P813) Friday, September 29, 2017

(Q37901851)
(P248)
(P854) https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4122326
(P813) Friday, September 29, 2017

(Q35049778)
(P248)
(P854) https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4122326
(P813) Friday, September 29, 2017

(Q40972751)
(P248)
(P854) https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4122326
(P813) Friday, September 29, 2017

(Q36735206)
(P248)
(P854) https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4122326
(P813) Friday, September 29, 2017

(Q39936654)
(P248)
(P854) https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4122326
(P813) Friday, September 29, 2017

(Q34009330)
(P248)
(P854) https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4122326
(P813) Friday, September 29, 2017

(Q35652261)
(P248)
(P854) https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4122326
(P813) Friday, September 29, 2017

(Q40242515)
(P248)
(P854) https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4122326
(P813) Friday, September 29, 2017

(Q51011205)
(P248)
(P854) https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4122326
(P813) Tuesday, November 27, 2018

(Q45976168)
(P248)
(P854) https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4122326
(P813) Tuesday, November 27, 2018

other details
aliases Activating mTOR Mutations in a Patient with an Extraordinary Response on a Phase I Trial of Everolimus and Pazopanib
description scientific article

External Links
(P356) 10.1158/2159-8290.CD-13-0353
(P698) 24625776
(P932) 4122326
(P3181) 3338469